Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02018653 · ClinicalTrials.gov registry record · NA
CASAD for Severe Diarrhea in the Emergency Department
A NA study, sponsored by M.D. Anderson Cancer Center.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT02018653: Clinical Trial NA study, sponsored by M.D. Anderson Cancer Center.
NCT02018653 is a NA study that was terminated before completion, run by M.D. Anderson Cancer Center. The registered enrollment target is 2 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02018653, a NA study, was terminated before completion, sponsored by M.D. Anderson Cancer Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
The goal of this clinical research study is to learn if calcium alumina-silicate (CASAD) can help to stop your diarrhea. Researchers also want to know if this drug can help decrease the duration of your diarrhea. In this study, CASAD will be compared to a placebo. A placebo is not a drug. It looks like the study drug but it is not designed to treat any disease or illness. It is designed in this study to be compared with the study drug to learn if the study drug has any real effect.
Interventions
- OTHER Placebo
- BEHAVIORAL Questionnaire
- DRUG Calcium Alumina-Silicate (CASAD)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2013-12 |
| Est. Completion | 2014-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02018653
The ClinicalTrials.gov registry entry for NCT02018653 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT02018653 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02018653 about?
NCT02018653 is a clinical study titled "CASAD for Severe Diarrhea in the Emergency Department". The goal of this clinical research study is to learn if calcium alumina-silicate (CASAD) can help to stop your diarrhea. Researchers also want to know if this drug can help decrease the duration of your diarrhea. In this study, CASAD will be compared to a placebo. A placebo is not a drug. It looks ...
What is the current status of trial NCT02018653?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2013-12. Estimated completion is 2014-08.
What interventions are being tested in trial NCT02018653?
The interventions under investigation include: Placebo (OTHER), Questionnaire (BEHAVIORAL), Calcium Alumina-Silicate (CASAD) (DRUG).
Who is sponsoring clinical trial NCT02018653?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.